National Brain Tumor Society’s Support of GBM AGILE
National Brain Tumor Society, along with the National Foundation for Cancer Research (NFCR) and the Asian Fund for Cancer Research, is a key strategic partner for GCAR and the GBM AGILE platform, providing philanthropic and advocacy support.
NBTS was there when the concept for this type of adaptive trial was first born in a meeting with leaders from across the neuro-oncology field, when the trial was announced with fanfare (including a cameo from then Vice President, and now, President-elect Joe Biden) in Washington, D.C., and made two substantial investments in the trial’s operations in 2019, totaling more than $1.25 million. We continue to support GBM AGILE as a major, revolutionary approach to clinical trials for patients with a brain tumor. We will keep the community updated when we learn important news about the trial.
“NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says David Arons, chief executive officer, National Brain Tumor Society. “As a patient advocacy partner to the GBM AGILE program, we truly believe that this dynamic, nimble platform offers more opportunities for patients with glioblastoma to access promising therapies in development and hope for new treatment approvals for a patient population that currently lacks adequate options to fight this devastating disease. With the urgency of now, GBM AGILE is exactly the kind of innovation we need to transform brain tumor clinical research to change the unacceptable status quo facing patients and their families with glioblastoma.”
NBTS thanks the Global Coalition for Adaptive Research, the patients involved in the study, the trial’s investigators and participating biopharmaceutical companies, and other partners, including NFCR and StacheStrong, together with support from the Uncle Kory Foundation, for their collaboration on this important trial.
For questions regarding philanthropic support for GBM AGILE, please contact the NBTS Development Office at donations@braintumor.org or 617-237-1731.